Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial Spasm

• Status: Unknown status
• Trial end date: 2013-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether zinc supplements are effective in enhancing the treatment of oculofacial spasm disorders with botulinum toxin.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: St. Joseph's Healthcare Hamilton
• Treatments: Botulinum Toxins; Zinc

Criteria

Inclusion Criteria:

• greater than the age 18 years old

• patient with hemifacial spasm

• patient with benign essential blepharospasm.

Exclusion Criteria:

• patients who have received Botox within 3 months time,

• patients prone to malabsorption (i.e. those with Celiac disease, inflammatory bowel disease, liver disease, laxative use)

• patients who cannot tolerate zinc supplementation due to kidney disease, gastrointestinal disease, or any other medical condition.